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Summary: Influence of various cytostatic agents on intracellular ATP concentrations of malignant cell lines
was studied. The HL-60 promyelocytic cell line, the SW-480 cell line, derived from an adenocarcinoma of
the colon and the SW-620 cell line, derived from a lymphonodal metastasis of the colon carcinoma, were
investigated. Cell lines were incubated with cytostatie agents and changes in intracellular ATP concentrations
were measured after variptis incubation times by means of bioluminescence.
A marked fall in intracellular ATP concentrations was observed, when HL-60 cells were incubated with drugs
used in clinical protocols for treatment of acute leukaemia (daunorubicin, vinblastine, vincristine), whereas
only a slight decrease of ATP concentrations was measured after incubation with bleomycin, dacarbazin and
prednisolone. The decrease in intracellular ATP concentrations of SW-480 and SW-620 cells was much less
pronounced after incubation with cytostatic agents compared to the HL-60 cells. This is in accordance with
the clinical experience of the knpwn resistance of colon carcinoma against cytostatic agents. Dose-response
curves were obtained for the single cytostatic agents. Comparison of intracellular ATP concentrations and
cell yiability äs determined by the trypan blue and eosin dye exclusion test showed that the trypan blue dye
exclusion test underestimated cell kill compared to the eosin dye exclusion test and the bioluminescence
assay.
Anwendung der Biolumineszenz zur Bestimmung des Einflusses von Chemotherapeutika auf ATP-Konzentrationen
maligner Zellinien
Zusammenfassung: Der Einfluß verschiedener Cytostatika auf intrazelluläre ATP-Konzentrationen maligner
Zellinien wurde untersucht. Die HL-60 promyelocytäre Zellinie, die SW-480, die aus einem Adenokarzinom
des Colons und die SW-620, die aus einer Lymphknotenmetastase desselben Patienten isoliert wurden, wurden
verwendet. Die Zellinien wurden mit Zytostatika inkubiert und die intrazellulären ATP-Konzentrationen
nach verschiedenen Inkubationszeiten unter Anwendung der Biolumineszenz bestimmt.
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Nach Inkubation der HL-60 Zellen mit Cytostatika, die auch in klinischen Therapieprotokollen für akute
Leukämien angewendet werden (Daunorubicin, Vinblastin, Vincristin), wurde ein deutlicher Abfall der
intrazellulären ATP-Konzentrationen beobachtet, während nach Inkubation mit Bleomycin, Dacarbazin
oder Prednisolon nur geringgradige Veränderungen des ATP-Gehaltes gemessen wurden. Entsprechend der
klinischen Erfahrung über die bekannte Resistenz von Colonkarzinomen gegenüber Cytostatika war der Abfall
intrazellulärer ATP-Konzentrationen bei SW-480- und SW-620-Colonkarzinomzellinien nach Inkubation mit
Zytostatika viel geringer ausgeprägt als bei HL-60-Zellen. Für die einzelnen Cytostatika wurden Dosis-
Wirkungskurven ermittelt. Der Vergleich intrazellulärer ATP-Konzentrationen mit der Zellviabilität, die mit
Farbausschlußtests mit Eosin oder Trypanblau bestimmt wurde, zeigte, daß der Zelltod mit dem Trypanblau-
Farbausschlußtest unterbewertet wird gegenüber der Bestimmung des Zelltodes mit dem Eosin-Farbaus-
schlußtest oder dem Biolumineszenz-Assay für ATP.
Introduction
Analysis of the intracellular concentration öf high-
energy phosphates can be used to measure the energy
Status of cells. Since cells maintain their ATP concen-
tration nearly constant under physiological condi-
tions, metabolic disturbances, e. g. by toxic agents,
will result in a rapid decrease of the total amount of
ATP (l, 2). Furthermore, cell death is accompanied
by a rapid and complete loss of ATP (3, 4). It should
therefore be possible to investigate the influence of
cytostatic agents on cancer cell metabolism by mea-
suring the ATP concentrations in malignant cells.
This might be important for pretherapeutic testing of
cytostatic agents in cancer patients. In recent years
several methods including dye exclusion tests (5),
isotopic incorporation tests using labeled thymidine
(6) and colony forming tests (7) have been applied in
pretherapeutic drug sensitivity testing.
In the present study changes in the ATP content of
the SW-480 and SW-620 adenocarcinoma cell line
and of HL-60 promyelocytic cells, exposed to various
cytostatic agents, were measured. Intracellular ATP
concentrations were determined using firefly biolumi-
nescence. Dose-response curves were derived for var-
ious cytostatic agents. Intracellular ATP content and
dye exclusion tests using trypan blue and eosin for
determination of drug induced cytotoxicity were com-
pared.
Materials and Methods
Cell lines
HL-60 are a unique human cell line that was developed from
peripheral blood leukocytes of a patient with acute promyelocy-
tic leukaemia by Collins et al. (8). The cultured cells display
distinct morphological and histochemical myeloid characteris-
tics.
SW-480 was isolated from a primary adenocarcinoma arising
in the colon, whereas SW-620 was isolated from a lymph node
when the cancer recufred with wide spread metastasis. Both
cell lines were derived from the same patient (9).
All in vitro experiments with HL-60 cells were carried out in
medium RPMI1640 (RPMI1640 with 2.0 g/l sodium bicarbon-
ate without glutamine, Flpw Laboratories, Irvine, U. K.) con-
taining 0.002 mol/1 glutamine, 100 ml/1 foetal calf serum and
0.1 g/l geiitamycin.
Colon tumour cell lines were cultivated in Leibovitz L 15 me-
dium supplemented with 100 ml/l foetal calf serum, 10 g/l
insulin and 10 mg/1 cortisol.
Cytotoxicity testing
Prior to incubations with chemotherapeutic agents cells were
harvested and resuspended in medium to yield a cell count of
0.1 109/1· Sterile plastic or siliconized glass wäre was used
in all procedures. The cell suspensions were distributed int o
test tubes, and cytostatic agents were dissolved in medium and
added to the cell suspensions to give a final drug concentration
shown in table 1. Drug concentrations were the same äs used
in clinical protocols, but calculated äs if they would distribute
only in the extracellular fluid. From the test tubes the cell
suspensions were distributed into micro titer plates, and the
drugs remained for the entire culture period in the test plates.
To study dose-response relationships cytostatic agents were
diluted up to l : 50 (maximal concentrations are shown in tab.
1) in culture medium and added to the cell suspensions.
Treated cells and cytostatic-free control incubations were held
under tissue culturing conditions (5% CÖ2 atmosphere humid-
ified incubator at 37 °C). Intracellular ATP was determined in
the specimens and in drug-free control incubations after various
culture periods. Bach value represents the mean of a triple
determination.
ATP determination
Intracellular ATP concentrations in HL-60 and colon carci-
n'oma cell lines were determined by the firefly bioluminescence
method. To liberale ATP froin the cells, the nonionic detergent,
ethoxy alkylphenol (NRS®, Lumac, Basel, Switzerland), was
used. Cell suspensions were diluted l : 5 in 0.02 mol/1 tris buffer
pH 7.75 containing 2mmol/l EDTA, and 100 NRS® was
added to 25 of the diluted cell Suspension. The reaction was
started by addition of 100 of a luciferin-lüciierase Suspension
(Lumit® PM, Lümac, Basel, Switzerland). The number of
photons released subsequently by the luciferin-luciferase reac-
tion , with ATP was meäsured using the "Bipcounter TM-M-
200" from Lumac (Lumac, Basel, Switzerland). The digitally
displayed integrated relative light units were recorded and the
ATP concentration was obtained üsing an internal standard-
ization technique.
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Tab. 1. Drug concentrations in vitro.
Drug (INN) Registered trade mark Manufacturer Concentration
( / cell
Suspension)
Doxorubicin Adriblastin Farmitalia, Carlo Erba, Freiburg i. B.,
FRG
11.4
Bleomycin
4-Hydroperoxy-cyclophosphamide
Cytarabine
Dacarbazin
Daunorubicin
Fluorouracil
Mercaptopurine
Mitomycin
Prednisolone
Etoposide
Vinblastine
Vincristine
Bleomycin Lundbeck
-*)
Alexan
DTIC-Dome
Daunoblastin
Fluoro-Uracil "Röche"
6-Mercaptopurine
Mitomycin C "Kyowa"
Prednisolon "Linz"
Vepesid
Velbe
Oncovin
H. Lundbeck, Kopenhagen, Denmark
Asta, Brackwede, FRG
Mack, Illertissen, FRG
Miles Laboratories, Stoke Poges,
Bucks., U. K.
Farmitalia, Carlo Erba, Freiburg i. B.,
FRG
Hoffmann — La Röche, Basel,
Switzerland
Sigma Chemical Co., St. Louis, Mo.,
U. S. A.
Kyowa Hakko Kogyo, Tokio, Japan
Chemie-Linz, Linz, Austria
Bristol-Myers, Bergisch-Gladbach, FRG
Eli-Lilly, Giessen, FRG
Eli-Lilly, Giessen, FRG
1.4
119.3
205.6
181.1
11.7
507.3
78.1
1.2
16.7
17.0
0.9
0.2
*) We thank Dr. V. Lierter from ASTA, Brackwede, FRG, for providing this substance, which is a derivative of cyclophosphamide
active in vitro.
Daily determination of the ATP Standard (500 fmol per test)
showed a CV of 5.4%. For the precision of ATP determinations
in cell extracts a CV (within a run) of 3% was calculated.
Dye exclusion tests
Pye exclusion tests using trypän blue (10) and eosin (11) were
performed to estimate cell death following exposure to cyto-
toxic drugs. Cell suspensions were examined under a bright
field microscope, 100 cells were counted for each experimental
value recorded. Viable cells were identified by their ability to
exclude dye, nonviable cells were stained by the dye.
Results
To evaluäte the sensitivity and linearity of the ATP
determination, cell suspensions were diluted down to
156 cells per test, using 0.02 mol/1 tris buffer pH 7.75,
containing 2mmol/l EDTA. Good linearity from
156—1250 cells per test was observed with all 3 cell
types studied (fig. 1). Mean ATP concentrations in
the SW-480 cells (5 experiments) were 9.1 ± 1.46
(SD) fmol/cell, in SW-620 (5 experiments) 12.1 ±
1.57 fmol/cell and in HL-60 cells (5 experiments)
4.4 ± 0.22 fmol/cell. HL^60 cells showed a marked
decrease in intracellular ATP when doxorubicin, 4-
hydroperoxycyclophosphamide, vinblastine and vin-
cristine were added to the cell suspensions (fig. 2),
the drugs being present during the whole culture
period (üp to 6 days). No significant decrease in
intracellular ATP was found when HL-60 cells were
incubated with bleomycin, dacarbazine or predniso-
lone. Since drug-^induced cell death was indicated
within a 2-day culture period, subsequent experi-
ments were conducted over a 48-hour incubation
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Fig. 1. Determination of intracellular ATP concentration in
HL-60 promyelocytic cells (V-V), in SW-480 (o-o)
and SW-620 (e —o) colon carcinoma cell lines using
firefly bioluminescence.
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period. ATP concentrations in the drug-free control
incubations of HL-60, SW-480 and SW-620 cells over
a culture period of 48 hours are shown in figure 3.
Dose-response curves were derived for drugs which
showed an effect on intracellular ATP (fig. 4). Sensi-
tivity of SW-480 (fig. 5) and SW-620 (fig. 6) colon
carcinoma cell lines against cytostatic agents was
much less pronounced compared to HL-60 cells (fig.
7). Comparison of intracellular ATP coricentrations
and cell viability, s detennined by the trypan-blue
and eosin-dye exclusion tests, showed that there was
a general agreement between the tests, but the tryp n
bhie dye exclusion test underestimated cell kill com-
pared to the eosin-dye exclusion test and the biolumi-
nescence assay (fig. 8).
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Fig. 2. Influence of various cytostatic agents on ATP concen-
trations in HL-60 promyelocytic cells (pmol ATP/25 μΐ
diluted cell Suspension). Drug concentrations used in
the experiments are listed in tab. 1. (o —O drug-free
control incubation; Δ — Δ prednisolone; D — D bleomy-
cin; V — V dacarbazine; Δ — Λ vincristine; b —n vin-
blastine; o —o doxorubicin; V — V 4-hydroperoxy-cy-
clophosphamide).
Dilution
Γ.20
1:5
1:2
1:1
= 205.6
μπτνοΐ/ΐ
Dilution
1:20
1:10
Incubation time L h J
Dilution
1:20
Fig. 4. Dose-response curves for cytosine arabinoside, 4-hydro-
peroxyrcyclophosphami.de, vinbiastine and vincristine
in HL-60 promyelocytic cells. (For highest drug concen-
trations cf. also tab. 1; these drug concentrations were
diluted s indicated.
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Fig. 3. ATP concentrations (χ ± SD) in the drug-free control
incubations of HL-60 (N = 5; o-o), SW-480 (n = 5;
Δ - Δ) and SW-620 cells (n = 5; A - A) over a 48-
hour culture period (pmol ATP/25 μΐ diluted cell s spen-
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Fig. 5. ATP concentrations of SW-480 colon carcinoma cell
lines after a 48-hour incubation period with cytostatic
agents (cf. tab. 1) (5 experiments 4- SD).
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j Fig. 6. ATP concentrations of SW-620 colon carcinoma cell Fig. 7. ATP concentrations of HL-60 promyelocytic cells after
I lines after a 48-hour incubation period with cytostatic a 48-hour incubation time with cytostatic agents (cf.
agents (cf. tab. 1) (5 experiments + SD). tab. 1) (5 experiments -h SD).
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Fig. 8. Comparison of intracellular ATP concentrations and cell viability s determined by eosin and trypan blue dye exclusion
tests in HL^oO eells after a 48-hour incubation period with doxorubicin (cf. tab. 1).
Discussion
Vario s test Systems have been designed tp detect
drug-induced cytptpxicity in malignant cells in vitro.
A classic method for testing the loss of reproducibility
of cancer cells is the colony-forming technique (7).
However, agar cloning assays are time consuming
and technical disadvantages limit their applicatioti in
preclinical drug screening (12).
Determination of drug-induced cytotoxicity was also
performed using tibe dye exclusion assays; Durkin et
al. (5) reported a good correlation between the in
vivo responsiveness and the in vitro results using the
trypan blue dye exclusion assay. Weisehthal et al. (13)
compared a novel fast green dye exclusion method
with a clonogenic assay. Both assays were in qualita-
tive agreement for the drugs tested, but the Standard
agar cloning assay gave somewhat higher estimates
of cell kill than the dye exclusion method. The main
drawback of dye exclusion assays is the impossibility
of detecting the various degrees of morbidity which
can occur in cells from the vital Status to cell death.
J? Clin. Chem. Clin. Bioobent. / Vol. 24,1986 / No. 5
298 Kuzmits et al.: Influence of chemotherapeutics on cell ATP
Application of firefly bioluminescence provides a ra-
pid and sensitive method to determine intracellular
ATP in cells. The method is sensitive enough to detect
ATP concentrations up to l O"18 mol ATP in a sample
(14). As the total amount of ATP in the samples was
rather low, this method proved sufficiently sensitive
and enabled rapid and precise determinations of ATP
in only small amounts of cell material (e. g. 500 cells
per test). In addition, the detennination is very rapid,
results of one detennination being obtained within
10 seconds. However, the method requires an optimal
single cell Suspension, but can also be applied to
solid tumours if one succeeds in separating the cell
associations.
Assessment of other high energy phosphates, such äs
ADP, AMP and cAMP, is also possible by means
of bioluminescence. Especially the adenylate energy
Charge, which can be calculated from the ATP, ADP
and AMP concentrations, indicates very accurately
the metabolic state of the cells, but its detennination
requires much more time. As the method used should
enable rapid pretherapeutic screening of cytostatic
drugs in cancer patients, we limited our efforts to
the measurement of the most important component,
ATP.
Incubation of HL-60 cells with cytostatic drugs used
in clinical protocols for treatment of leukaemia
patients led to a marked decrease in intracellular ATP
concentrations. The decrease in intracellular ATP
concentrations was much less pronounced after incu-
bation with various cytostatic agents in SW-480 and
SW-620 adenocarcinoma cells. No differences in the
effect of cytostatics on intracellular ATP concentra-
tions were observed between the cell line derived from
the primary tumour (SW-480) and the cell line derived
from the metastasis (SW-620). These results are in
accordance with the clinical experience of the known
resistance of colorectal carcinomas against most cyto-
static agents.
A clear dose-^response relationship could be demon-
strated for Various cytostatic agents.
Comparison of the bioluminescence assay and dye
exclusion tests shöwed that comparable results were
obtained with the bioluminescence assay and the eo-
sin dye exclusion test, whereas cell death was under-
estimated by the tfypaii blüe dye exclusion test. Cell
damage is indicated by a drop in intracellular ATP
concentrations, which makes it possible to obtain a
result between 6 and 25 hoürs earlier than by the
trypan blüe dye exclusion test.
Determination of drug-induced cytotoxicity by the
firefly bioluminescence assay might be used to detect
resistance or sensitivity of leukaemic cells to cyto-
static agents in vitro. Application of the test for
solid tumours is possible, but an optimal single cell
Suspension is required in this test System. Further
work will be necessary to evaluate the in vitro results
and the in vivo responsiveness in cancer patients.
Studies on the application of the test System for
pretherapeutic drug testing in acute leukaemia are in
progress. .
 ;,
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